These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 20876310)

  • 1. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.
    Corzo CA; Condamine T; Lu L; Cotter MJ; Youn JI; Cheng P; Cho HI; Celis E; Quiceno DG; Padhya T; McCaffrey TV; McCaffrey JC; Gabrilovich DI
    J Exp Med; 2010 Oct; 207(11):2439-53. PubMed ID: 20876310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
    Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
    Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
    Kumar V; Gabrilovich DI
    Immunology; 2014 Dec; 143(4):512-9. PubMed ID: 25196648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
    Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
    Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice.
    Köstlin-Gille N; Dietz S; Schwarz J; Spring B; Pauluschke-Fröhlich J; Poets CF; Gille C
    Front Immunol; 2019; 10():161. PubMed ID: 30804946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.
    Doedens AL; Stockmann C; Rubinstein MP; Liao D; Zhang N; DeNardo DG; Coussens LM; Karin M; Goldrath AW; Johnson RS
    Cancer Res; 2010 Oct; 70(19):7465-75. PubMed ID: 20841473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Deng J; Li J; Sarde A; Lines JL; Lee YC; Qian DC; Pechenick DA; Manivanh R; Le Mercier I; Lowrey CH; Varn FS; Cheng C; Leib DA; Noelle RJ; Mabaera R
    Cancer Immunol Res; 2019 Jul; 7(7):1079-1090. PubMed ID: 31088847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis.
    Liu G; Bi Y; Shen B; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Liao J; Chen X; Chu Y
    Cancer Res; 2014 Feb; 74(3):727-37. PubMed ID: 24351289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
    Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
    Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
    Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
    Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
    Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
    Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.